The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases

Completed

Conditions studied: Cancer, Inflammation

In brief

The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.

Key facts

Study ID

NCT01180907

Run by

Jonsson Comprehensive Cancer Center

People needed

10

Starts

2007-11-01

Last updated by the study team

2012-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• > 18 years of age
• women of childbearing potential will undergo a pregnancy test free of charge
• patients with cancer or autoimmune diseases or healthy subjects

Where it is running

• UCLA — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.